Research Stories

Showing 1 to 10 of 64 results
CityU’s 3T MRI animal scanner
Diagnosis of Alzheimer’s disease, the most common type of dementia, is not easy for its overlapping signs with normal ageing. A collaborative research by City University of Hong Kong (CityU) and Johns Hopkins University has developed a new non-invasive molecular imaging approach based on Magnetic Resonance Imaging (MRI) to dynamically measure glucose level changes in the brain lymphatic system. Their discovery may help in identifying Alzheimer’s disease at early stages so that treatments can start as soon as possible.
Professor Samuel Ho, Associate Dean (Faculty and Research) of College of Liberal Arts and Social Sciences, and Professor of Psychology at Department of Social and Behavioural Sciences at City University of Hong Kong (CityU), has been researching on factors that facilitate people’s psychological adjustments to traumatic events. One of his research includes tracing medical staff and recovered patients of the 2003 SARS outbreak. Based on theoretical and empirical studies, he has developed an in-depth knowledge of increasing self-efficacy and fostering positive emotions, which can help cope with the stress brought by COVID-19.
Schematic diagram_in vivo priming
A stem cell biologist from CityU, together with his collaborators, has developed a novel strategy, called in vivo priming, to “train” the stem cells to stay strong after implantation to the damaged heart via the 3D-printed bandage-like patch.
An international research team led by scientists from City University of Hong Kong (CityU) has recently discovered that high-entropy alloys (HEAs) exhibit exceptional mechanical properties at ultra-low temperatures due to the coexistence of multiple deformation mechanisms. Their discovery may hold the key to design new structural materials for applications at low temperatures.
Professor Alex Jen Kwan-yue, CityU
All-inorganic perovskite solar cells have drawn increasing attention because of their outstanding thermal stability. A research team led by scholars from City University of Hong Kong (CityU) has recently developed a new type of all-inorganic inverted perovskite solar cell through passivation.
Dr Ivan Borzenets, Kondo cloud
Physicists have been trying to observe the quantum phenomenon Kondo cloud for many decades. An international research team comprising a scientist from City University of Hong Kong (CityU) has recently developed a novel device that successfully measures the length of the Kondo cloud and even allows for controlling the Kondo cloud.
Professor He,novel photoelectrochemical system
Researchers from the City University of Hong Kong (CityU) and King Abdullah University of Science and Technology have joined hands and successfully developed a novel photoelectrochemical system, which can greatly improve the solar-to-hydrogen conversion efficiency from 3% to nearly 9%. It is more stable, with stability lasting for over 150 hours, highest among its counterparts. And its cost is 50% lower.
Dr Sean Yuan Hsiang-yu
As the spread of the novel coronavirus (COVID-19) epidemic continued, the effectiveness of existing quarantine measures is one of the major concerns. An expert in mathematical modelling for infectious diseases at City University of Hong Kong (CityU) estimated that there was a 3.5-day time gap between patients showing COVID-19 symptoms and being quarantined in Hong Kong. And in this case, there will be a possible increase of around 60 infected cases from mid-February to mid-March.
cityu, city university of hong kong
City University of Hong Kong (CityU) aims at excelling in research and professional education, as well as promoting innovation. Faculty members are committed in research and innovations that support social, economic and technological advancement. CityU’s efforts are highly recognized, as reflected in the improvement in different rankings.
Dr Chow Kwan Ting,City University of Hong Kong
Cancer immunotherapy has drawn increasing attention in recent years. Although still at its infancy, it has brought hope to many cancer patients. Exploring the anti-tumour activities of a rare immune cell type in the human body is the focus of a research project led by a biomedical scientist and her research team at City University of Hong Kong (CityU). The research findings will provide insights into designing new generations of cancer immunotherapy and vaccine against different cancers.
Back to top